About Biotest
Biotest is a company based in Dreieich (Germany) founded in 1946 by Carl Adolf Schleussner and Hans Schleussner was acquired by Grifols in September 2021.. The company has 1,119 employees as of December 31, 2019. Biotest offers products and services including Yimmugo, Haemoctin, Cytotect, and Albiomin.
- Headquarter Dreieich, Germany
- Employees 1119 as on 31 Dec, 2019
- Founders Carl Adolf Schleussner, Hans Schleussner
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biotest Ag
-
Annual Revenue
$116.71 K (USD)210as on Dec 31, 2023
-
Net Profit
$111.84 K (USD)254as on Dec 31, 2023
-
EBITDA
-
Latest Funding Round
$266.37 M (USD), Debt – Conventional
Aug 28, 2019
-
Investors
Alcentra
& 3 more
-
Employee Count
1119
as on Dec 31, 2019
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biotest
Biotest offers a comprehensive portfolio of products and services, including Yimmugo, Haemoctin, Cytotect, and Albiomin. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides therapy for immune deficiencies and infections
Treats hemophilia and bleeding disorders effectively
Offers protection against viral infections in patients
Supports intensive care for volume replacement needs
Unlock access to complete
Unlock access to complete
Funding Insights of Biotest
- Total Funding Total Funding
- Total Rounds 1
- Last Round Debt – Conventional — $266.4M
-
First Round
First Round
(28 Aug 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2019 | Amount | Debt – Conventional - Biotest | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biotest
Biotest has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Alcentra, Grifols and Berenberg. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Alcentra is engaged in alternative credit management and investment.
|
Founded Year | Domain | Location | |
|
Private bank providing wealth management, corporate banking, and asset management solutions.
|
Founded Year | Domain | Location | |
|
Plasma-derived therapies are developed to treat multiple diseases.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biotest
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biotest
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biotest Comparisons
Competitors of Biotest
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biotest
Frequently Asked Questions about Biotest
When was Biotest founded?
Biotest was founded in 1946 and raised its 1st funding round 73 years after it was founded.
Where is Biotest located?
Biotest is headquartered in Dreieich, Germany. It is registered at Dreieich, Hessen, Germany.
Who is the current CEO of Biotest?
Michael Ramroth is the current CEO of Biotest.
How many employees does Biotest have?
As of Dec 31, 2019, the latest employee count at Biotest is 1,119.
What is the annual revenue of Biotest?
Annual revenue of Biotest is $116.71K as on Dec 31, 2023.
What does Biotest do?
Biotest was founded in 1946 in Dreieich, Germany, as a manufacturer and provider of plasma proteins and biological drugs. Operations focus on the biotechnology sector, with products encompassing immunoglobulins, coagulation factors, and albumins for clinical immunology, haematology, and intensive medicine. Monoclonal antibodies are also developed in the pipeline for treating cancer and systemic lupus erythematosus.
What products or services does Biotest offer?
Biotest offers Yimmugo, Haemoctin, Cytotect, and Albiomin.
Who are Biotest's investors?
Biotest has 4 investors. Key investors include Alcentra, Grifols, Berenberg, and Creat Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.